Relmada Therapeutics (RLMD) Shareholder's Equity (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 Relmada Therapeutics 595.35 Mn 595.35 Mn - 218.73 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 218.73 Mn
Dec 31, 2025 86.51 Mn
Sep 30, 2025 9.47 Mn
Jun 30, 2025 15.95 Mn
Mar 31, 2025 22.44 Mn
Dec 31, 2024 35.52 Mn
Sep 30, 2024 47.63 Mn
Jun 30, 2024 61.49 Mn
Mar 31, 2024 72.05 Mn
Dec 31, 2023 85.36 Mn
Sep 30, 2023 100.73 Mn
Jun 30, 2023 111.34 Mn
Mar 31, 2023 125.47 Mn
Dec 31, 2022 140.44 Mn
Sep 30, 2022 166.34 Mn
Jun 30, 2022 196.85 Mn
Mar 31, 2022 210.40 Mn
Dec 31, 2021 208.26 Mn
Sep 30, 2021 72.69 Mn
Jun 30, 2021 96.85 Mn
Mar 31, 2021 91.15 Mn
Dec 31, 2020 105.58 Mn
Sep 30, 2020 122.21 Mn
Jun 30, 2020 132.23 Mn
Mar 31, 2020 113.16 Mn
Dec 31, 2019 115.68 Mn
Sep 30, 2019 5.98 Mn
Jun 30, 2019 7.61 Mn
Mar 31, 2019 473,898.00
Dec 31, 2018 1.43 Mn
Sep 30, 2018 -8.68 Mn
Jun 30, 2018 -5.51 Mn
Mar 31, 2018 -2.32 Mn
Dec 31, 2017 721,158.00
Sep 30, 2017 1.46 Mn
Jun 30, 2017 1.46 Mn
Mar 31, 2017 2.80 Mn
Dec 31, 2016 4.67 Mn
Sep 30, 2016 5.57 Mn
Jun 30, 2016 7.04 Mn
Mar 31, 2016 10.20 Mn
Dec 31, 2015 11.76 Mn
Sep 30, 2015 13.84 Mn
Jun 30, 2015 8.81 Mn
Mar 31, 2015 2.49 Mn
Dec 31, 2014 4.59 Mn
Sep 30, 2014 -20.72 Mn
Jun 30, 2014 -1.11 Mn
Nov 30, 2013 -28,031.00
Aug 31, 2013 -13,657.00
May 31, 2013 -21,293.00
Feb 28, 2013 -1,808.00
Aug 31, 2012 11,358.00